ZFP36L2 and ovarian carcinoma: The result showed that ZFP36L2 was highly expressed in colorectal cancer, lower-grade gliomas, leukemia, hepatic cancer, ovarian cancer, pancreatic cancer and gastric cancer compared with normal tissues.